Related Experiment Video
Updated: Mar 20, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
995
Pharmaceutical competency among physicians: a multidimensional assessment incorporating self-perceived and objective
Chao Liu1, Hanyang Guo1, Bingyi Li1
1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China.
International Journal of Clinical Pharmacy
|March 18, 2026
Summary
Physicians overestimate their pharmaceutical competency, showing high self-assessments but low objective scores. Enhancing pharmaceutical education and support systems is crucial for safe medication use.
Area of Science:
- Medical Education
- Clinical Pharmacy
- Pharmacology
Background:
- Growing complexity of pharmacotherapies increases medication-related risks.
- Physicians' pharmaceutical competencies may not meet demands for safe medication use.
- Existing assessments lack multidimensional evaluation of pharmaceutical competency.
Purpose of the Study:
- Assess pharmaceutical competency in Chinese physicians during continuing medical education.
- Examine associations with professional titles, clinical pharmacist presence, training, and rational drug use systems.
Main Methods:
- Cross-sectional survey of physicians in Chinese tertiary hospitals.
- Combined subjective self-assessment and objective testing for pharmaceutical competency.
- Descriptive statistics and subgroup analyses to identify influencing factors.
Main Results:
- 1,044 physicians participated; median subjective score was 3.92/5, median objective accuracy was 51.11%.
- No significant differences in competency across professional titles.
- Clinical pharmacist presence and hospital training correlated with higher subjective and objective scores.
Conclusions:
- Physicians tend to overestimate their pharmaceutical competency.
- Need to strengthen pharmaceutical education and medication management support for physicians.
- Pharmacist involvement, training, and rational drug use systems are key to improving competency and medication safety.
Keywords:
Clinical pharmacyContinuing medical educationDrug utilizationPharmaceutical servicesPhysiciansMore Related Videos
Related Concept Videos
01:20Measurement of Bioavailability: Pharmacodynamic Methods
939
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
939
01:27Pharmacodynamic Models: Overview
71
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
71
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
67
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
67
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
212
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
212
01:15Drug Dosing: Geriatric Patients
344
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
344
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
248
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248